Cav3.2 is upregulated in stages III and IV of medulloblastoma, the most common pediatric malignant brain tumor, and the level of expression correlates with aggressiveness, the occurrence of metastasis, and worsens clinical outcomes. Here, CACNA1H is linked to medulloblastoma.